Canada Goose (NYSE:GOOS) Stock Price Up 10.4% – Still a Buy?

Canada Goose Holdings Inc. (NYSE:GOOS)’s share price was up 10.4% during mid-day trading on Monday . The company traded as high as $11.59 and last traded at $11.50. Approximately 752,483 shares were traded during trading, a decline of 20% from the average daily volume of 937,134 shares. The stock had previously closed at $10.41.

Analyst Ratings Changes

Several equities research analysts have recently commented on GOOS shares. Barclays reduced their price target on shares of Canada Goose from $11.00 to $10.00 and set an “equal weight” rating for the company in a research report on Monday, February 10th. Evercore ISI decreased their price target on shares of Canada Goose from $13.00 to $10.00 and set an “in-line” rating on the stock in a research report on Monday, February 10th. Finally, The Goldman Sachs Group cut their price objective on shares of Canada Goose from $9.00 to $8.00 and set a “sell” rating for the company in a research report on Tuesday, December 10th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Canada Goose has an average rating of “Hold” and a consensus price target of $10.60.

Canada Goose Stock Up 11.9 %

The company has a market capitalization of $1.13 billion, a PE ratio of 22.39, a price-to-earnings-growth ratio of 1.00 and a beta of 1.31. The company’s fifty day moving average is $10.26 and its 200-day moving average is $10.45. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.14 and a current ratio of 2.01.

Canada Goose (NYSE:GOOS) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.10 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.10. Canada Goose had a net margin of 5.47% and a return on equity of 22.49%. As a group, analysts predict that Canada Goose Holdings Inc. will post 0.7 EPS for the current fiscal year.

Institutional Investors Weigh In On Canada Goose

Institutional investors and hedge funds have recently bought and sold shares of the business. The Manufacturers Life Insurance Company grew its position in shares of Canada Goose by 42.9% during the third quarter. The Manufacturers Life Insurance Company now owns 5,554,279 shares of the company’s stock worth $69,595,000 after purchasing an additional 1,667,750 shares in the last quarter. Patient Capital Management LLC boosted its stake in Canada Goose by 3.4% in the 4th quarter. Patient Capital Management LLC now owns 3,854,520 shares of the company’s stock worth $38,661,000 after purchasing an additional 128,133 shares during the period. Arrowstreet Capital Limited Partnership bought a new position in Canada Goose in the 4th quarter worth approximately $12,251,000. Scheer Rowlett & Associates Investment Management Ltd. grew its holdings in Canada Goose by 1.2% during the 4th quarter. Scheer Rowlett & Associates Investment Management Ltd. now owns 1,218,326 shares of the company’s stock valued at $12,223,000 after buying an additional 14,341 shares in the last quarter. Finally, Pinnacle Associates Ltd. raised its position in shares of Canada Goose by 0.6% during the third quarter. Pinnacle Associates Ltd. now owns 602,341 shares of the company’s stock valued at $7,138,000 after buying an additional 3,338 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Canada Goose Company Profile

Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.